Myeloid Neoplasm with PDGFRA Rearrangement Manifesting as a Retromolar Pad Mass

Head Neck Pathol. 2021 Dec;15(4):1399-1403. doi: 10.1007/s12105-021-01305-9. Epub 2021 Feb 22.

Abstract

Myeloid neoplasms with PDGFRA rearrangement are rare, and most commonly present with features of chronic eosinophilic leukemia; however, they rarely manifest as acute myeloid or lymphoblastic leukemia. Patients typically present with symptoms of hypereosinophilia including cardiovascular and pulmonary symptoms. An increase in mast cells is also a common feature of this disease, and there may be elevated serum tryptase with significant clinical overlap with systemic mastocytosis. Here, we present an unusual case of a myeloid neoplasm with PDGFRA rearrangement manifesting as a retromolar pad mass in a patient with a prior diagnosis of systemic mastocytosis. This case highlights the possibility of soft tissue involvement by myeloid neoplasms with PDGFRA rearrangement in the oral cavity. The identification of this entity is of significant clinical importance because many patients can be effectively treated with tyrosine kinase inhibitors.

Keywords: Eosinophilia; Gingiva; Mastocytosis; Oral pathology; PDGFRA-associated myeloproliferative neoplasm; Tyrosine kinase inhibitor.

Publication types

  • Case Reports

MeSH terms

  • Aged
  • Biomarkers, Tumor / analysis
  • Biopsy
  • Diagnosis, Differential
  • Gene Rearrangement
  • Humans
  • Hypereosinophilic Syndrome / diagnosis*
  • Hypereosinophilic Syndrome / genetics*
  • Hypereosinophilic Syndrome / pathology
  • Leukemia / diagnosis*
  • Leukemia / genetics*
  • Leukemia / pathology
  • Male
  • Mouth Neoplasms / diagnosis*
  • Mouth Neoplasms / genetics*
  • Mouth Neoplasms / pathology
  • Soft Tissue Neoplasms / diagnosis*
  • Soft Tissue Neoplasms / genetics*
  • Soft Tissue Neoplasms / pathology

Substances

  • Biomarkers, Tumor

Supplementary concepts

  • Pdgfra-Associated Chronic Eosinophilic Leukemia